Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Information (Details)

v3.19.1
Stock-Based Compensation - Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Stock-Based Compensation    
Available for grant (in shares) 700,741  
Share-based compensation costs recognized $ 3,082 $ 1,606
Employees    
Stock-Based Compensation    
Remaining unamortized expense $ 2,846  
Remaining unamortized expense period 1 year 8 months 12 days  
Non-Employees    
Stock-Based Compensation    
Remaining unamortized expense $ 527  
Remaining unamortized expense period 1 year 2 months 12 days  
Options    
Stock-Based Compensation    
Share-based compensation costs recognized $ 2,872 1,168
Options | BioXcel Corporation    
Stock-Based Compensation    
Share-based compensation costs recognized $ 210 $ 439